Investing

BioMarin : BMRN

BMRN

Stock Data

$53.31

$0.32 (0.60%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

BioMarin Pharmaceutical Inc. specializes in creating innovative treatments for individuals facing serious and life-threatening rare diseases. With a portfolio that includes enzyme replacement therapies like Vimizim for mucopolysaccharidosis and Naglazyme for MPS VI, BioMarin stands out in the pharmaceutical field. The company also offers Kuvan for phenylketonuria, Palynziq to manage blood phenylalanine levels, Brineura for Batten disease, Voxzogo for achondroplasia, and Aldurazyme for issues related to the enzyme alpha-L-iduronidase. Additionally, BioMarin is developing Roctavian for severe hemophilia A, demonstrating its commitment to addressing unmet medical needs worldwide. Founded in 1996, BioMarin is headquartered in San Rafael, California.

All BioMarin Articles

167 Articles

Eric Bleeker | Oct 27, 2025 at 7:08 PM EDT

Biomarin Up After Q3 Earnings: Here’s Everything You Need to Know

BioMarin Pharmaceutical (Nasdaq: BMRN) missed both revenue and earnings estimates in the third quarter, and yet, shares are up 1% in…

Trey Thoelcke | Feb 5, 2025 at 8:45 AM EST

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big…

Lee Jackson | Jul 6, 2023 at 8:55 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: AMD, Coinbase, Conagra Brands, Coty, Hertz, Netflix, Plug Power, Rivian, Transocean, US Steel and More

Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Coherent, Coinbase Global, Conagra Brands, Coty, Hertz Global, Netflix, Plug…

Lee Jackson | Jul 5, 2023 at 8:49 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Amazon, Lucid, Nike, Tesla, Valero Energy, Walgreens, Wells Fargo and More

Wednesday's top analyst upgrades and downgrades included Amazon.com, BioMarin Pharmaceutical, Constellation Brands, Dominion Energy, Lucid, Nike, Southern Company, Tesla, Valero…

Lee Jackson | Mar 22, 2023 at 8:53 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Alphabet, Foot Locker, Meta Platforms, New York Community Bancorp, Nvidia, Rio Tinto and More

Wednesday's top analyst upgrades and downgrades included Alphabet, Danaher, Emerson Electric, Foot Locker, GoDaddy, Harley-Davidson, Meta Platforms, New York Community…

Lee Jackson | Mar 17, 2023 at 8:16 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: Adobe, Citigroup, FedEx, Foot Locker, Intel, Nike, Qualcomm, Under Armour and More

Friday's top analyst upgrades and downgrades included Adobe, Citigroup, FedEx, Foot Locker, Hewlett Packard Enterprise, Intel, Medical Properties Trust, Nike,…

Lee Jackson | Feb 22, 2023 at 8:51 AM EST

Wednesday’s Top Analyst Upgrades and Downgrades: Constellation Energy, DraftKings, Mosaic, Norfolk Southern, Nvidia, RingCentral, Riot Platforms, SentinelOne and More

Wednesday's top analyst upgrades and downgrades included BioMarin Pharmaceutical, BlackRock, CF Industries, Constellation Energy, DocuSign, DraftKings, Mosaic, Norfolk Southern, Nvidia,…

Lee Jackson | Feb 7, 2023 at 7:14 AM EST

5 Goldman Sachs Conviction List Stock Pick Winners With 50% to 75% Upside Potential

These five top Goldman Sachs Conviction List stock picks have the largest upside to the firm's target prices. Growth investors…

Lee Jackson | Nov 30, 2022 at 8:49 AM EST

Wednesday’s Top Analyst Upgrades and Downgrades: Delta Air Lines, Microchip Technology, Philip Morris, Pinduoduo, Shopify and More

Wednesday's top analyst upgrades and downgrades included APA, Delta Air Lines, Generac, Lululemon Athletica, Microchip Technology, Paccar, Philip Morris International, Pinduoduo,…

Lee Jackson | Nov 9, 2022 at 8:54 AM EST

Wednesday’s Top Analyst Upgrades and Downgrades: Amgen, ADM, Eli Lilly, Home Depot, Medtronic, Palantir, Snowflake, Take-Two Interactive, Walgreens and More

Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two…

Chris Lange | Oct 31, 2022 at 12:35 PM EDT

With Fed Rate Hike Incoming, Analysts Upgrade or Downgrade AMD, Gilead Sciences, Paramount and More

Monday’s additional top analyst upgrades and downgrades were on Advanced Micro Devices, Amgen, BioMarin Pharmaceutical, Caterpillar, Gilead Sciences, Hanesbrands, Honeywell…

Lee Jackson | Aug 26, 2022 at 8:50 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: Danaher, First Majestic Silver, First Solar, Illumina, KB Home, NetApp, Nvidia, Salesforce, Snowflake and More

Friday’s top analyst upgrades and downgrades included Danaher, Exact Sciences, First Majestic Silver, First Solar, Illumina, KB Home, NetApp, Nvidia,…

Lee Jackson | Jun 29, 2022 at 7:23 AM EDT

5 Sizzling Goldman Sachs Conviction List Stocks to Buy Now With 100% or More Upside Potential

These five stock picks from the Goldman Sachs Conviction List offer ideas for aggressive investors with longer time horizons and…

Lee Jackson | Jun 28, 2022 at 8:51 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Atlassian, DraftKings, eBay, Fortinet, LyondellBasell, Riot Blockchain and More

Tuesday's top analyst upgrades and downgrades included Atlassian, Autodesk, BioMarin Pharmaceutical, Darden Restaurants, DraftKings, eBay, Fortinet, LyondellBasell Industries, Riot Blockchain…

Chris Lange | Jun 13, 2022 at 10:59 AM EDT

From Bad to Even Worse: Analysts Upgrade or Downgrade Micron Technology, T. Rowe Price, Zendesk and More

Monday's additional top analyst upgrades and downgrades included BioMarin Pharmaceutical, Micron Technology, Quanta Services, Sangamo Therapeutics, Silvergate Capital, T. Rowe…